News
Wall Street Analysts Believe Beyond (BYON) Could Rally 57.32%: Here's is How to Trade
Shares of Beyond (BYON) have gained 18.9% over the past four weeks to close the last trading session at $8.95, but there could still be a solid upside left in the stock if short-term price targets
Wall Street Analysts Predict a 26.72% Upside in Gentherm (THRM): Here's What You Should Know
Gentherm (THRM) closed the last trading session at $32.04, gaining 4.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Bears are Losing Control Over Futu Holdings (FUTU), Here's Why It's a 'Buy' Now
A downtrend has been apparent in Futu Holdings Limited Sponsored ADR (FUTU) lately. While the stock has lost 7.9% over the past week, it could witness a trend reversal as a hammer chart pattern was
Does Kiniksa Pharmaceuticals International, plc (KNSA) Have the Potential to Rally 35.96% as Wall Street Analysts Expect?
Kiniksa Pharmaceuticals International, plc (KNSA) closed the last trading session at $30.26, gaining 8.5% over the past four weeks, but there could be plenty of upside left in the stock if
After Golden Cross, Invesco (IVZ)'s Technical Outlook is Bright
Invesco Ltd. (IVZ) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, IVZ's 50-day simple moving average broke out above its 200-day
CNB (CCNE) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Shares of CNB Financial (CCNE) have been struggling lately and have lost 5.9% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the
Wall Street Analysts See a 44.47% Upside in Omnicell (OMCL): Can the Stock Really Move This High?
Omnicell (OMCL) closed the last trading session at $31.01, gaining 3.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts Believe Rapt Therapeutics (RAPT) Could Rally 122.22%: Here's is How to Trade
Shares of Rapt Therapeutics (RAPT) have gained 34.2% over the past four weeks to close the last trading session at $10.8, but there could still be a solid upside left in the stock if short-term
Camden's Q2 FFO & Revenues Beat Estimates, '25 View Raised
Camden Property Trust CPT reported second-quarter 2025 core funds from operations (FFO) per share of $1.70, surpassing the Zacks Consensus Estimate of $1.69. However, the figure marginally declined
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Here's Why TD SYNNEX (SNX) is a Strong Momentum Stock
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The research service
Why Invesco (IVZ) is a Top Momentum Stock for the Long-Term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research
Why TE Connectivity (TEL) is a Top Momentum Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Why Humana (HUM) is a Top Momentum Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The research service
Why FMC Technologies (FTI) is a Top Momentum Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The popular research
Here's Why Astrazeneca (AZN) is a Strong Momentum Stock
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service
Why Universal Health Services (UHS) is a Top Growth Stock for the Long-Term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research
Why Waters (WAT) is a Top Growth Stock for the Long-Term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
Featuring daily updates
Here's Why Shake Shack (SHAK) is a Strong Growth Stock
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates
Why Blackbaud (BLKB) is a Top Growth Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different